Caricamento...
An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is one of the most widespread degenerative disorders in elderly people. A 90-day, open-label clinical study was conducted in 40 patients, aged 50 years or older, with early-stage dry-type AMD to evaluate the safety and efficacy of Macumax(®), a novel mixture of...
Salvato in:
| Pubblicato in: | J Med Food |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mary Ann Liebert, Inc., publishers
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8140349/ https://ncbi.nlm.nih.gov/pubmed/33180005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jmf.2020.0097 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|